| Competing endogenous RNA networks as biomarkers in neurodegenerative diseases L Moreno-García, T López-Royo, AC Calvo, JM Toivonen, M de la Torre, ... International Journal of Molecular Sciences 21 (24), 9582, 2020 | 81 | 2020 |
| Cx3cr1‐deficiency exacerbates alpha‐synuclein‐A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease S Castro‐Sánchez, ÁJ García‐Yagüe, T López‐Royo, M Casarejos, ... Glia 66 (8), 1752-1762, 2018 | 56 | 2018 |
| Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology A Navarro-Romero, I Fernandez-Gonzalez, J Riera, M Montpeyo, ... npj Parkinson's Disease 8 (1), 1-15, 2022 | 27 | 2022 |
| What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy R Manzano, JM Toivonen, L Moreno‐Martínez, M de la Torre, ... British Journal of Pharmacology 178 (6), 1279-1297, 2021 | 22 | 2021 |
| Type XIX collagen: a promising biomarker from the basement membranes AC Calvo, L Moreno, L Moreno, JM Toivonen, R Manzano, N Molina, ... Neural Regeneration Research 15 (6), 988, 2020 | 17 | 2020 |
| Encapsulation of Large-Size Plasmids in PLGA Nanoparticles for Gene Editing: Comparison of Three Different Synthesis Methods T López-Royo, V Sebastián, L Moreno-Martínez, L Uson, C Yus, T Alejo, ... Nanomaterials 11 (10), 2723, 2021 | 12 | 2021 |
| Impaired signaling of Transcription factors NF-ƘB and NRF2 in CX3CR1-deficient microglia leads to altered neuroinflammation and phagocytosis: implications in tauopathies S Castro-Sánchez, ÁJ García-Yagüe, M Galán-Ganga, T López-Royo, ... | | 2018 |
